The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding the genomic underpinnings of metastatic chromophobe renal cell carcinoma.
 
Jozefina Casuscelli
No Relationships to Disclose
 
Patricia Wang
No Relationships to Disclose
 
Almedina Redzematovic
No Relationships to Disclose
 
William Lee
No Relationships to Disclose
 
Venkatraman E. Seshan
No Relationships to Disclose
 
Ronglai Shen
No Relationships to Disclose
 
Nicholas Donin
No Relationships to Disclose
 
Yingbei Chen
No Relationships to Disclose
 
John C. Cheville
No Relationships to Disclose
 
Allan J. Pantuck
No Relationships to Disclose
 
Robert Houston Thompson
Patents, Royalties, Other Intellectual Property - Patent for B7-H1 and survivin as prognostic markers in renal cell carcinoma.
 
Jonathan A. Coleman
No Relationships to Disclose
 
Paul Russo
No Relationships to Disclose
 
Victor E. Reuter
No Relationships to Disclose
 
Satish Tickoo
No Relationships to Disclose
 
A. Ari Hakimi
No Relationships to Disclose
 
James Hsieh
Honoraria - Chugai Pharma
Consulting or Advisory Role - Chugai Pharma; Novartis
Research Funding - Novartis; Pfizer